Metyylprednisoloni

Metyylprednisoloni is a synthetic corticosteroid medication used to reduce inflammation and suppress the immune system. It is a potent glucocorticoid, similar in action to cortisol, a hormone naturally produced by the adrenal glands. Metyylprednisoloni works by binding to glucocorticoid receptors in cells, which in turn affects the expression of genes involved in inflammation and immune responses. This leads to a decrease in the production of inflammatory mediators like cytokines and prostaglandins, and a reduction in the activity of immune cells.

It is prescribed for a wide range of conditions, including allergic reactions, asthma, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, autoimmune diseases like rheumatoid arthritis and lupus, and certain types of cancer. Metyylprednisoloni can be administered orally, intravenously, intramuscularly, or topically, depending on the condition being treated and the desired speed and location of effect.

Common side effects associated with metyylprednisoloni use can include increased appetite, weight gain, mood changes, difficulty sleeping, and increased risk of infection. Long-term or high-dose use can lead to more serious side effects such as osteoporosis, thinning of the skin, cataracts, glaucoma, and adrenal suppression. It is important to use metyylprednisoloni under the guidance of a healthcare professional to minimize risks and ensure appropriate dosage and duration of treatment. Withdrawal from the medication should be gradual to allow the body's natural adrenal function to recover.